Abstract

In situ heart valve tissue engineering is an emerging approach in which resorbable, off-the-shelf available scaffolds are used to induce endogenous heart valve restoration. Such scaffolds are designed to recruit endogenous cells in vivo, which subsequently resorb polymer and produce and remodel new valvular tissue in situ. Recently, preclinical studies using electrospun supramolecular elastomeric valvular grafts have shown that this approach enables in situ regeneration of pulmonary valves with long-term functionality in vivo. However, the evolution and mechanisms of inflammation, polymer absorption and tissue regeneration are largely unknown, and adverse valve remodeling and intra- and inter-valvular variability have been reported. Therefore, the goal of the present study was to gain a mechanistic understanding of the in vivo regenerative processes by combining routine histology and immunohistochemistry, using a comprehensive sheep-specific antibody panel, with Raman microspectroscopy for the spatiotemporal analysis of in situ tissue-engineered pulmonary valves with follow-up to 24 months from a previous preclinical study in sheep. The analyses revealed a strong spatial heterogeneity in the influx of inflammatory cells, graft resorption, and foreign body giant cells. Collagen maturation occurred predominantly between 6 and 12 months after implantation, which was accompanied by a progressive switch to a more quiescent phenotype of infiltrating cells with properties of valvular interstitial cells. Variability among specimens in the extent of tissue remodeling was observed for follow-up times after 6 months. Taken together, these findings advance the understanding of key events and mechanisms in material-driven in situ heart valve tissue engineering. Statement of significanceThis study describes for the first time the long-term in vivo inflammatory and regenerative processes that underly in situ heart valve tissue engineering using resorbable synthetic scaffolds. Using a unique combinatorial analysis of immunohistochemistry and Raman microspectroscopy, important spatiotemporal variability in graft resorption and tissue formation was pinpointed in in situ tissue-engineered heart valves, with a follow-up time of up to 24 months in sheep. This variability was correlated to heterogenous regional cellular repopulation, most likely instigated by region-specific differences in surrounding tissue and hemodynamics. The findings of this research contribute to the mechanistic understanding of in situ tissue engineering using resorbable synthetics, which is necessary to enable rational design of improved grafts, and ensure safe and robust clinical translation.

Highlights

  • Surgical or interventional valve replacement is the standard of care treatment for most patients with severe symptomatic valvular heart disease, and this treatment improves quality of life and prolongs survival

  • This study describes for the first time the long-term in vivo inflammatory and regenerative processes that underly in situ heart valve tissue engineering using resorbable synthetic scaffolds

  • The present study extends the depth of analysis of the specimens, including two additional explants with 24 months follow-up, to yield a deeper understanding of the processes involved

Read more

Summary

Introduction

Surgical or interventional valve replacement is the standard of care treatment for most patients with severe symptomatic valvular heart disease, and this treatment improves quality of life and prolongs survival. Surgical valve replacement with either mechanical or tissue valve substitutes (the latter composed of animal or human tissue and often called bioprostheses) generally yield favorable long-term outcomes; survival is 50-70% at 10-15 years following valve replacement [1]. Valve-related problems necessitate reoperation or cause death in more than half of patients with substitute valves within 10-15 years postoperatively [2,3]. Mechanical valves induce platelet deposition and blood coagulation, (i.e., thrombosis) necessitating lifelong anticoagulation to reduce the risk of prosthetic valve-related blood clots in patients receiving them. Despite improvements in tissue treatments intended to enhance durability, bioprostheses frequently suffer structural valve degeneration, often resulting from calcification, which is accelerated in children and young adults [4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.